Literature DB >> 6246102

Human placental adenosine kinase. Kinetic mechanism and inhibition.

T D Palella, C M Andres, I H Fox.   

Abstract

The kinetic properties of human placental adenosine kinase, purified 3600-fold, were studied. The reaction velocity had an absolute requirement for magnesium and varied with the pH. Maximal activity was observed at pH 6.5 with a Mg2+:ATP ranging from 1:1 to 2:1. High concentrations of Mg2+ or free ATP were inhibitory. Double reciprocal plots of initial velocity studies yielded intersecting lines for both adenosine and MgATP2-. The Michaelis constant was 0.4 micro M for adenosine and 75 micro M for MgATP2-. Inhibition by adenosine was observed at concentrations greater than 2.5 micro M. AMP was a competitive inhibitor with respect to adenosine and a noncompetitive inhibitor with respect to ATP. ADP was a noncompetitive inhibitor with respect to adenosine and ATP. Hyperbolic inhibition was observed during noncompetitive inhibition of adenosine kinase by AMP and ADP. Other purine and pyrimidine nucleoside mono-, di-, and triphosphates were poor inhibitors in general. S-Adenosylhomocysteine and 2'-deoxyadenosine inhibited adenosine kinase. The data suggest that (a) MgATP2- is the true substrate of adenosine kinase, and both pH and [Mg2+] may regulate its activity; (b) the kinetic mechanisms of adenosine kinase is Ordered Bi Bi; and (c) adenosine kinase may be regulated by the concentrations of its products, AMP and ADP, but is relatively insensitive to other purine and pyrimidine nucleotides.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246102

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Nitric oxide-stimulated increase in extracellular adenosine accumulation in rat forebrain neurons in culture is associated with ATP hydrolysis and inhibition of adenosine kinase activity.

Authors:  P A Rosenberg; Y Li; M Le; Y Zhang
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 2.  PRPS1 mutations: four distinct syndromes and potential treatment.

Authors:  Arjan P M de Brouwer; Hans van Bokhoven; Sander B Nabuurs; Willem Frans Arts; John Christodoulou; John Duley
Journal:  Am J Hum Genet       Date:  2010-04-09       Impact factor: 11.025

3.  Homology-model-guided site-specific mutagenesis reveals the mechanisms of substrate binding and product-regulation of adenosine kinase from Leishmania donovani.

Authors:  Rupak Datta; Ishita Das; Banibrata Sen; Anutosh Chakraborty; Subrata Adak; Chhabinath Mandal; Alok K Datta
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

4.  Crystal structure of adenosine kinase from Toxoplasma gondii at 1.8 A resolution.

Authors:  W J Cook; L J DeLucas; D Chattopadhyay
Journal:  Protein Sci       Date:  2000-04       Impact factor: 6.725

5.  Identification and characterization of a unique adenosine kinase from Mycobacterium tuberculosis.

Authors:  Mary C Long; Vincent Escuyer; William B Parker
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

6.  Properties of rat heart adenosine kinase.

Authors:  M N Fisher; E A Newsholme
Journal:  Biochem J       Date:  1984-07-15       Impact factor: 3.857

7.  Phosphorylated derivatives that activate or inhibit mammalian adenosine kinase provide insights into the role of pentavalent ions in AK catalysis.

Authors:  Jae Park; Bhag Singh; Mary C Maj; Radhey S Gupta
Journal:  Protein J       Date:  2004-02       Impact factor: 2.371

Review 8.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

9.  Phosphorylation of adenosine in anoxic hepatocytes by an exchange reaction catalysed by adenosine kinase.

Authors:  F Bontemps; M Mimouni; G Van den Berghe
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

10.  Adenosine Kinase of T. b. Rhodesiense identified as the putative target of 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine using chemical proteomics.

Authors:  Sabine Kuettel; Marc Mosimann; Pascal Mäser; Marcel Kaiser; Reto Brun; Leonardo Scapozza; Remo Perozzo
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.